DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

References

Jackisch C, Hegg R, Stroyakovskiy D et al.
Total pathologic complete response (tpCR) and event-free survival (EFS) with subcutaneous (SC) or intravenous (IV) trastuzumab in HER2-positive early breast cancer (EBC): The HannaH phase III study.

J Clin Oncol 2015;
33 (Suppl.) Abstr. 585

Download Bibliographical Data

Search in: